SCP-7155
Unknown
~
medium confidence
SCP-7155
Expected annual
$33K
One-time setup
$225K
Annual recurring
$29K
One-time setup and initial analytical testing are the main costs (lab characterization, test chamber setup, and contingency reserves), with modest annual operating costs driven by testing, monitoring, and upkeep.
One-Time Capital Costs
Total: $225K
Annual Recurring Costs
Total: $29K/yr
Cost Scenarios
📊
Baseline
(baseline)
$29K/yr
Normal year with routine monitoring, occasional on-site tests, no major incidents or public exposure.
scheduled testing
routine inspections
minor consumable replacement
🚨
Minor Incident
$39K/yr
Small containment/cleanup event or contamination requiring extra cleanup, additional testing days, and limited overtime/PR.
minor spill or contamination
unexpected small-scale test anomaly
🚨
Major Breach
$279K/yr
Reclassification or containment failure requiring dedicated containment upgrade, major repairs, prolonged research response and extended staffing.
discovery of hazardous/proliferative properties
containment failure requiring vault/ suppression upgrade
🚨
Public Exposure
$129K/yr
Accidental public disclosure requiring emergency response, PR/ legal operations, cleanup, and liability management.
accidental public discovery
unauthorized data leak or visible contamination
Personnel
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 0 | No dedicated full-time guard budgeted in baseline; costs are a pro-rata allocation of existing site security. [#4] |
| Research Scientist | 0 | Research time budgeted as contracted/temporary per-test days rather than a dedicated FTE in baseline. [#6, #15] |
| Technician | 0 | Technician hours are project-based and included in per-test research budget; no dedicated headcount budgeted. [#15] |
| Administrative Staff | 0 | Administrative and EHS tasks handled by site staff allocations and consultants; overhead included in insurance/overhead. [#11, #20] |
Confidence Notes
Analyst notes provide detailed line-item ranges, allowing medium confidence in baseline recurring and one-time estimates; uncertainty remains about anomalous properties and frequency/severity of adverse events (hence not high).